Comparing Computerized Short-Term Variation Analysis and Visual Cardiotocography to Guide Delivery Timing in Severe Early-Onset Fetal Growth Restriction
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-11-04
800
Participants Needed
6
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether using short-term variation STV analysis in fetal monitoring improves perinatal survival compared to the usual visual evaluation of cardiotocography CTG in pregnant women with severe, early-onset fetal growth restriction FGR before 32 weeks of gestation. This condition affects about 0.3% of pregnancies and presents a challenge in deciding the best time to deliver the baby to balance risks of early birth and fetal hypoxia. The study aims to clarify if computer software analysis of fetal heart rate variability can better guide delivery timing than visual CTG interpretation.
The study compares two monitoring methods visual interpretation of CTG and computer software analysis measuring the short-term variation in fetal heart rate. Pregnant women with singleton pregnancies between 24 and 31 weeks and 6 days diagnosed with severe FGR will be randomly assigned to either monitoring method. The monitoring is done during hospital admission or frequent outpatient evaluations following local protocols.
Participants will be closely monitored with these methods until delivery. Researchers will assess outcomes including the proportion of pregnancies resulting in perinatal death before discharge from neonatal intensive care, major and minor neonatal complications, and neurodevelopmental impairment at two years corrected age. The study involves data collection through fetal monitoring and follow-up assessments up to two years after birth, with a total study duration extending to 2029.
CONDITIONS
Brief Title
STV Analysis Versus Visual Evaluation of Cardiotocography in FGR
Research Team
W
Wessel Ganzevoort, MD PhD
A
Anouk Pels, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
Who Can Participate
Age: 18Years - 99Years
FEMALE
Eligibility Criteria
You may qualify if you...
Pregnant women with a singleton pregnancy between 24 weeks 0 days and 31 weeks 6 days with severe, early-onset fetal growth restriction, admitted in hospital or frequently monitored by cardiotocography
Severe fetal growth restriction defined by ultrasound abdominal circumference or estimated fetal weight below the 3rd percentile, or estimated fetal weight below the 10th percentile combined with high uterine or umbilical artery Doppler measurements
Maternal age 18 years or older
Ability to provide written informed consent in the study language
You will not qualify if you...
Known congenital or chromosomal anomalies affecting perinatal outcome
Imminent labor or expected need for delivery within 48 hours due to maternal reasons
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - From enrollment until delivery, between 24 and 32 weeks gestation
Participants are monitored using either visual cardiotocography or computer software analysis of short-term variation to guide delivery timing.
Frequent hospital or outpatient cardiotocography evaluations as per local protocols
Follow-up
Duration - Up to 2 years after birth
Researchers assess neonatal outcomes and neurodevelopmental status up to two years after birth.
Follow-up visits and assessments according to study schedule
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Maternal Melatonin Supplementation to Protect Brain Development in Severe Early Preterm Fetal Growth Restriction
Study of Lactoferrin and DHA Supplements in Pregnant Women with Fetal Growth Restriction
Impact on Babys Brain Development and Birth Outcomes
Study of a Structured Ultrasound Program for Monitoring Fetal Growth and Reducing Stillbirth Risks in Pregnant Women at Oxford University Hospitals
PROTECT-Africa Validating Biomarker Tests to Improve Preeclampsia Care in African Pregnancies
International Study on Selective Fetal Growth Restriction in Monochorionic Diamniotic Twin Pregnancies
Improving Diagnosis, Outcome Prediction, and Parental Support
Comparing Computerized Short-Term Variation Analysis and Visual Cardiotocography to Guide Delivery Timing in Severe Early-Onset Fetal Growth Restriction
Testing New Non-Stick Sensors to Monitor Babys Heartbeat and Movements in Late Pregnancy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The SAVE FGR study: Short term variation Analysis versus Visual Evaluation of cardiotocography in early-onset Fetal Growth Restriction to trigger expedited birth - study protocol for a stepped wedge cluster randomized trial.